ETFdb Logo
  • ETF Database
  • Channels
    • Themes
      • Active ETF
      • Alternatives Channel
      • Artificial Intelligence
      • China Insights
      • Climate Insights
      • Core Strategies
      • Crypto
      • Disruptive Technology
      • Energy Infrastructure
      • ETF Building Blocks
      • ETF Education
      • ETF Investing
      • ETF Strategist
      • Faith-Based Investing
      • Financial Literacy
      • Fixed Income
      • Free Cash Flow
      • Innovative ETFs
      • Invest Beyond Cash
      • Leveraged & Inverse
      • Modern Alpha
      • Portfolio Strategies
      • Tax Efficient Income
    • Asset Class
      • Equity
        • U.S. Equity
        • Int'l Developed
        • Emerging Market Equities
      • Alternatives
        • Gold/Silver/Critical Materials
        • Crypytocurrency
        • Currency
        • Volatility
      • Fixed Income
        • Investment Grade Corporates
        • US Treasuries & TIPS
        • High Yield Corporates
        • Int'l Fixed Income
    • ETF Ecosystem
    • ETFs in Canada
    • Market Outlook
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Database Categories
    • Indexes
    • Scenario Analysis
    • Watchlists
    • Head-To-Head ETF Comparison Tool
    • Mutual Fund To ETF Converter
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • Gaining Perspective Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
    • Get VettaFi’ed
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Disruptive Technology Channel
  2. This Stock Is The Second-Largest Weight in ARKK
Disruptive Technology Channel
Share

This Stock Is The Second-Largest Weight in ARKK

Nick Peters-GoldenDec 19, 2022
2022-12-19

There’s a new top-three player in ARK’s flagship ETF, the ARK Innovation Fund (ARKK B). Despite CEO Cathie Wood’s spree of contrarian plays for stocks like Tesla (TSLA) and Coinbase (COIN), it’s the Exact Sciences Corporation (EXAS) that is now the second-highest weighted stock in ARKK at 8.7%, just behind Zoom (ZM) at 9.2%, according to VettaFi. The new ARKK holding weights present an intriguing opportunity for investors given the state of the market and recent news at the molecular diagnostics firm.

EXAS spiked Thursday into Friday following news that its colorectal cancer test outperforms rival firm Guardant Health (GH)’s blood test for the same illness. EXAS is responsible for the first DNA stool test for colorectal cancer, Cologuard, which it launched in 2014. While GH’s test had an 83% sensitivity for detecting the cancer, Cologuard claims that its test has a 92% sensitivity rate.

That sent EXAS’ stock to a peak of $55.24 on Friday from $44.61 at the end of Thursday, though it has since dropped down to around $50.8. That price movement also took the strategy past its 200-Day Simple Moving Average of $47, though it has also just hit overbought territory according to the RSI Indicator.

EXAS topping TSLA shows that the flagship ARK ETF, often associated with TSLA, has more to offer than the electric car firm alone.

“While ARKK has become one of the most well-known ways to gain exposure to Tesla, there are many other positions inside that offer diversification benefits to shareholders,” said VettaFi head of research Todd Rosenbluth.

EXAS has received some interest in the second half of the year thanks to analyst excitement, with some positive price targets and a buy rating for Zacks last month. Investors looking at the stock may want to consider the merits of the new ARKK holding weights and its flows entering the new year. ARKK has added $1.43 billion over one year, charging 75 basis points. The ETF also provides a 1.74% annual dividend yield, according to VettaFi.

It’s been a difficult year for tech stocks, including biotech. The broad market selloff may just be a precursor for a rising rate-driven recession next year, but investors preparing for 2023 may still want tech exposure. ARKK could be a good option with the likes of EXAS and Cologuard on its side, and certainly always one to watch as one of the premier disruptive innovation offerings available in the ETF wrapper.

For more news, information, and analysis, visit our Disruptive Technology Channel.

Loading Articles...
Our Sites
  • VettaFi
  • Advisor Perspectives
  • ETF Trends
Tools
  • ETF Screener
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Database Pro
More Tools
  • Financial Advisor & RIA Center
Explore ETFs
  • ETF News
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Information
  • Contact Us
  • Terms of Use and Privacy Policy
  • © 2025 VettaFi LLC. All rights reserved.

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X